AAAAAA

   
Results: 1-13 |
Results: 13
Clinical comparative trials of angiotensin II type 1 (AT(1))-receptor blockers
Authors: Meredith, PA
Citation: Pa. Meredith, Clinical comparative trials of angiotensin II type 1 (AT(1))-receptor blockers, BLOOD PRESS, 10, 2001, pp. 11-17
Angiotensin II receptor antagonists: New paradigms in the treatment of hypertension - International Symposium on Angiotensin II Antagonism, London, UK, February 28, 2000 - Introduction
Authors: Meredith, PA Weber, MA
Citation: Pa. Meredith et Ma. Weber, Angiotensin II receptor antagonists: New paradigms in the treatment of hypertension - International Symposium on Angiotensin II Antagonism, London, UK, February 28, 2000 - Introduction, BLOOD PRESS, 10, 2001, pp. 4-5
Insights in the management of hypertension: Focus on amlodipine - Introduction
Authors: Meredith, PA
Citation: Pa. Meredith, Insights in the management of hypertension: Focus on amlodipine - Introduction, CARDIOLOGY, 96, 2001, pp. 1-2
Is postural hypotension a real problem with antihypertensive medication?
Authors: Meredith, PA
Citation: Pa. Meredith, Is postural hypotension a real problem with antihypertensive medication?, CARDIOLOGY, 96, 2001, pp. 19-24
The chronotherapeutics of hypertension
Authors: Meredith, PA
Citation: Pa. Meredith, The chronotherapeutics of hypertension, BL PRESS M, 5, 2000, pp. S1-S1
Intrinsically long-acting agents compared with long-acting chronoformulations
Authors: Meredith, PA
Citation: Pa. Meredith, Intrinsically long-acting agents compared with long-acting chronoformulations, BL PRESS M, 5, 2000, pp. S25-S30
ACE inhibition and AT(1) receptor blockers: efficacy and duration in hypertension
Authors: Meredith, PA
Citation: Pa. Meredith, ACE inhibition and AT(1) receptor blockers: efficacy and duration in hypertension, HEART, 84, 2000, pp. I39-I41
The importance of sustained blood pressure control
Authors: Meredith, PA
Citation: Pa. Meredith, The importance of sustained blood pressure control, J CARDIO PH, 35, 2000, pp. S7-S11
Evaluation of an antihypertensive therapy utilising meta-analysis of a clinical trial database
Authors: Meredith, PA
Citation: Pa. Meredith, Evaluation of an antihypertensive therapy utilising meta-analysis of a clinical trial database, J CARDIO PH, 35, 2000, pp. S1-S6
Mortality amongst patients of the Glasgow Blood Pressure Clinic was high in the 1970s and 80s but has fallen since, why?
Authors: Lever, AF Beevers, DG Hole, DJ Isles, CG Meredith, PA Murray, LS McInnes, GT Reid, JL
Citation: Af. Lever et al., Mortality amongst patients of the Glasgow Blood Pressure Clinic was high in the 1970s and 80s but has fallen since, why?, CLIN EXP HY, 21(5-6), 1999, pp. 553-562
Is cancer related to hypertension or to its treatment?
Authors: Lever, AF Hole, DJ Gillis, CR McInnes, GT Meredith, PA Murray, LS Reid, JL
Citation: Af. Lever et al., Is cancer related to hypertension or to its treatment?, CLIN EXP HY, 21(5-6), 1999, pp. 937-946
Optimal dosing characteristics of the angiotensin II receptor antagonist telmisartan
Authors: Meredith, PA
Citation: Pa. Meredith, Optimal dosing characteristics of the angiotensin II receptor antagonist telmisartan, AM J CARD, 84(2A), 1999, pp. 7K-12K
Can modern antihypertensive treatment prevent end-organ damage? Proceedings of a satellite symposium to the XVI Scientific Meeting of the International Society of Hypertension - Introduction
Authors: Macdonald, GJ Meredith, PA
Citation: Gj. Macdonald et Pa. Meredith, Can modern antihypertensive treatment prevent end-organ damage? Proceedings of a satellite symposium to the XVI Scientific Meeting of the International Society of Hypertension - Introduction, J HYPERTENS, 16, 1998, pp. S1-S1
Risultati: 1-13 |